• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险受益人中按种族分层的外周动脉疾病治疗的时间和地理趋势。

Temporal and Geographic Trends in the Treatment of Peripheral Arterial Disease Stratified by Race Among Medicare Beneficiaries.

作者信息

Vogel Birgit, Dangas Katerina, Di Muro Francesca Maria, Sartori Samantha, Oliva Angelo, Dangas George, Krishnan Prakash, Yoon Harrison, Etter Katherine, Erim Daniel, Pylypchuk Yuriy, Keever Rachel, Mehran Roxana

机构信息

Icahn School of Medicine at Mount Sinai, New York, New York.

Oxford University School of Medicine, Oxford, United Kingdom.

出版信息

JAMA Cardiol. 2025 Aug 1;10(8):820-828. doi: 10.1001/jamacardio.2025.1714.

DOI:10.1001/jamacardio.2025.1714
PMID:40498478
Abstract

IMPORTANCE

Racial disparities in the management of peripheral arterial disease (PAD) are well established. Analysis of the temporal trends and geographic variation in racial differences in the use of revascularization and major amputation may identify areas for targeted intervention.

OBJECTIVE

To investigate differences in the treatment of PAD between Black and White patients over time and by US state.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study examined data for Medicare fee-for-service beneficiaries with a PAD diagnosis between 2018 and 2022. Data were analyzed from November 14, 2023, to February 13, 2025.

EXPOSURES

Black and White race.

MAIN OUTCOMES AND MEASURES

The proportions of Black and White patients with PAD undergoing revascularization and major amputation were compared over time and by state. Data were adjusted for age, sex, hypertension, diabetes, tobacco use, chronic kidney disease, and county-level Social Vulnerability Index (SVI).

RESULTS

The total sample size was 2 376 300 beneficiaries (1 224 537 men [51.5%]). Black patients (219 338 [9.2%]) were slightly younger than White patients (2 156 962 [90.8%]; mean [SD] age, 75.8 [7.9] years vs 76.9 [7.8] years; P < .001) and had a higher prevalence of comorbidities. A higher proportion of Black patients (8.9%) than White patients (7.6%) underwent revascularization (odds ratio, 1.19 [95% CI, 1.18-1.21]; P < .001), and a higher proportion of Black patients (2.8%) than White patients (1.0%) underwent major amputation (odds ratio, 2.91 [95% CI, 2.83-2.99]; P < .001). Higher proportions of Black patients than White patients underwent revascularization and major amputation in the majority of states, although with marked variation in these proportional differences across states. The proportions of Black and White patients who underwent revascularization decreased over time (from 8.0% to 7.4% for Black patients and from 6.8% to 6.2% for White patients). The proportion of Black patients who underwent major amputation decreased (from 2.9% to 2.5%; P < .001), but there was no change among White patients (from 0.7% to 0.7%; P = .53). Revascularization correlated weakly (ρ = 0.10), and amputation correlated moderately with SVI (ρ = 0.46).

CONCLUSIONS AND RELEVANCE

These findings suggest that higher proportions of Black patients than White patients undergo invasive procedures for PAD, with considerable variation across states. Although the proportional difference in major amputations has narrowed over time, the persistent proportional excess of major amputations among Black patients requires further study to investigate whether this difference reflects remediable disparities in care.

摘要

重要性

外周动脉疾病(PAD)管理中的种族差异已得到充分证实。分析血管重建术和大截肢术使用方面种族差异的时间趋势和地理差异,可能会确定有针对性干预的领域。

目的

调查不同时间以及美国各州黑人和白人患者在PAD治疗上的差异。

设计、设置和参与者:这项队列研究检查了2018年至2022年间诊断为PAD的医疗保险按服务收费受益人的数据。数据于2023年11月14日至2025年2月13日进行分析。

暴露因素

黑人和白人种族。

主要结局和测量指标

比较不同时间以及各州接受血管重建术和大截肢术的黑人和白人PAD患者的比例。数据针对年龄、性别、高血压、糖尿病、吸烟、慢性肾病和县级社会脆弱性指数(SVI)进行了调整。

结果

总样本量为2376300名受益人(1224537名男性[51.5%])。黑人患者(219338名[9.2%])比白人患者(2156962名[90.8%])年龄稍小(平均[标准差]年龄,75.8[7.9]岁对76.9[7.8]岁;P<0.001),且合并症患病率更高。接受血管重建术的黑人患者比例(8.9%)高于白人患者(7.6%)(优势比,1.19[95%置信区间,1.18 - 1.21];P<0.001),接受大截肢术的黑人患者比例(2.8%)高于白人患者(1.0%)(优势比,2.91[95%置信区间,2.83 - 2.99];P<0.001)。在大多数州,接受血管重建术和大截肢术的黑人患者比例高于白人患者,尽管这些比例差异在各州有显著变化。接受血管重建术的黑人和白人患者比例随时间下降(黑人患者从8.0%降至7.4%,白人患者从6.8%降至6.2%)。接受大截肢术的黑人患者比例下降(从2.9%降至2.5%;P<0.001),但白人患者无变化(从0.7%降至0.7%;P = 0.53)。血管重建术与SVI的相关性较弱(ρ = 0.10),截肢术与SVI的相关性中等(ρ = 0.46)。

结论及意义

这些发现表明,接受PAD侵入性治疗的黑人患者比例高于白人患者,各州之间存在相当大的差异。尽管大截肢术的比例差异随时间有所缩小,但黑人患者中大截肢术比例持续过高,需要进一步研究以调查这种差异是否反映了可补救的医疗差异。

相似文献

1
Temporal and Geographic Trends in the Treatment of Peripheral Arterial Disease Stratified by Race Among Medicare Beneficiaries.医疗保险受益人中按种族分层的外周动脉疾病治疗的时间和地理趋势。
JAMA Cardiol. 2025 Aug 1;10(8):820-828. doi: 10.1001/jamacardio.2025.1714.
2
Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.转移性肾细胞癌患者治疗中的地区脆弱性和差异。
JAMA Netw Open. 2024 Apr 1;7(4):e248747. doi: 10.1001/jamanetworkopen.2024.8747.
3
Racial and Ethnic Disparities in Receipt of ERBB2-Targeted Therapy for Breast Cancer, 2010-2020.2010 - 2020年乳腺癌接受ERBB2靶向治疗中的种族和民族差异
JAMA Netw Open. 2025 May 1;8(5):e258086. doi: 10.1001/jamanetworkopen.2025.8086.
4
Cardiovascular Health at the Intersection of Race and Gender in Medicare Fee for Service.医疗保险服务收费中种族与性别的交叉点上的心血管健康
JAMA Health Forum. 2025 Aug 1;6(8):e253014. doi: 10.1001/jamahealthforum.2025.3014.
5
Race and Ethnicity and Comorbidities Among Medicare Beneficiaries With Young-Onset Dementia.患有早发性痴呆症的医疗保险受益人的种族、民族与合并症
JAMA Netw Open. 2025 Aug 1;8(8):e2528001. doi: 10.1001/jamanetworkopen.2025.28001.
6
Turning Tides: Evolving Comorbidity Profiles, Demographic Shift, and the Unexpected Rise of Major Lower Extremity Amputations.潮流转变:不断演变的合并症概况、人口结构变化以及下肢大截肢意外增加
Ann Surg. 2025 Sep 1;282(3):429-438. doi: 10.1097/SLA.0000000000006813. Epub 2025 Jun 23.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Outcomes following deep venous arterialization in Medicare patients with chronic limb-threatening ischemia.医疗保险慢性肢体威胁性缺血患者行深静脉动脉化后的结局
J Vasc Surg. 2025 Sep;82(3):1007-1013. doi: 10.1016/j.jvs.2025.04.003. Epub 2025 Apr 11.
9
Racial Differences in Adoption and Outcomes of Transcarotid Artery Revascularization among High-Risk Adults with Carotid Artery Stenosis.高危颈动脉狭窄成人经颈动脉血管重建术的采用情况及预后的种族差异。
Ann Vasc Surg. 2025 Apr;113:370-381. doi: 10.1016/j.avsg.2024.09.036. Epub 2024 Oct 2.
10
Racial and Ethnic Disparities in Health Care Use and Access Associated With Loss of Medicaid Supplemental Insurance Eligibility Above the Federal Poverty Level.医疗保健使用和获得方面的种族和族裔差异与超过联邦贫困水平的医疗补助补充保险资格丧失有关。
JAMA Intern Med. 2023 Jun 1;183(6):534-543. doi: 10.1001/jamainternmed.2023.0512.